Menu
Currency
GWAS Study

Genome-Wide Association Study Identifies Pharmacogenomic Variants Associated With Metformin Glycemic Response in African American Patients With Type 2 Diabetes.

Wu B

37639712 PubMed ID
GWAS Study Type
1266 Participants
32 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WB
Wu B
Chapter II

Abstract

Summary of the research findings

447 African American or Afro-Caribbean individuals

Chapter III

Study Statistics

Key metrics and study information

1266
Total Participants
GWAS
Study Type
Yes
Replicated
353 African American or Afro-Caribbean individuals, 466 European ancestry individuals
Replication Participants
African American or Afro-Caribbean, European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.